Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: a double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064) - O'Brien, Mary; Schmid-Bindert, Gerald (European journal of cancer, 2015)
Gesehen am 11.12.2018